Severe Hypoglycemia Caused by Paraneoplastic Production of IGF-II in Patients With Advanced Gastrointestinal Stromal Tumors: A Report of Two Cases

Daniel Pink(Universitätsmedizin Greifswald), Peter Reichardt(Helios Hospital Berlin-Buch), H. Knipp(Alfried Krupp Hospital), Tanja Lindner(Helios Hospital Berlin-Buch), Albrecht Kretzschmar(Roche (Switzerland)), D. Schoeler(Charité - Universitätsmedizin Berlin), U. Vanhoefer, Peter Thuss‐Patience(Charité - Universitätsmedizin Berlin)

Journal of Clinical Oncology

September 17, 2005

10.1200/jco.2005.02.4828

Cited by 70

Related Papers

Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial

|The Lancet|2019|2.6k

Soft tissue and visceral sarcomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up

|Annals of Oncology|2018|1.6k

Efficacy and safety of regorafenib for advanced gastrointestinal stromal tumours after failure of imatinib and sunitinib (GRID): an international, multicentre, randomised, placebo-controlled, phase 3 trial

|The Lancet|2012|1.4k

Gastrointestinal stromal tumours: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up

|Annals of Oncology|2018|751

Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohort

|European Journal of Cancer|2019|724